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The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucosi-
tis: a systematic review
 
Daily chlorhexidine mouthwash is often recommended for preventing chemotherapy-induced oral mucositis.
Povidone-iodine, NaCl 0.9%, water salt soda solution and chamomile mouthwash are also recommended.
However, the effectiveness of these mouthwashes is unclear. Therefore, we performed a systematic review to
assess the effectiveness of mouthwashes in preventing and ameliorating chemotherapy-induced oral mucositis.
Based on study quality, three out of five randomized controlled trials were included in a meta-analysis. The
results failed to detect any beneficial effects of chlorhexidine as compared with sterile water, or NaCl 0.9%.
Patients complained about negative side-effects of chlorhexidine, including teeth discoloration and alteration
of taste in two of the five studies on chlorhexidine. The severity of oral mucositis was shown to be reduced
by 30% using a povidone-iodine mouthwash as compared with sterile water in a single randomized controlled
trial. These results do not support the use of chlorhexidine mouthwash to prevent oral mucositis.
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INTRODUCTION
 
Oral mucositis occurs in about 40% of patients who
undergo cytostatic chemotherapy for malignancies (Scully
& Epstein 1996; Sonis 
 
et al
 
. 2004). Virtually every patient
who  has  undergone  myeloablative  therapy  to  prepare
for  a haematopoietic stem cell transplant (HSCT) devel-
ops mucositis, with 67% developing severe oral mucositis
(Wardley 
 
et al
 
. 2000).
Damage to the mucous membranes (mucositis) can
occur as a consequence of the direct effects of cytostatic
drugs on the rapidly dividing cells in the tissues in the
mouth. The initial symptoms of mucositis usually present
between the fourth and seventh day after chemotherapy
(Wojtaszek 2000). White discoloration of the mucous
membranes mostly precedes the redness, oedema and
lesions. These lesions can develop into large painful ulcers
that can seriously hinder eating and drinking (Rogers
2001). Furthermore, the protective effect of saliva can be
reduced – due to a decrease in the quality and quantity –
increasing the chance of developing infection (Carl &
Havens 2000; Epstein 
 
et al
 
. 2002).
Severe mucositis results in a significant reduction in the
quality of life, potential nutritional deficit and even the
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postponement of chemotherapy (Bolwell 
 
et al
 
. 2002). A
recent study among 92 stem cell transplant recipients in
eight centres in the United States, Canada and Europe
demonstrated that the amount and severity of oral
mucositis correlated with the number of days that
patients required intravenous antibiotics, analgesics and
parenteral feeding. The severity of mucositis among stem
cell transplant recipients was also correlated with the
number of admissions and readmissions, hospital costs
and mortality (Sonis 
 
et al
 
. 2001).
The high incidence and severe consequences of mucosi-
tis among patients who undergo chemotherapy underline
the importance of good prevention.
Rinsing the mouth daily with chlorhexidine solution is
a preventive measure frequently recommended by nurses.
Solutions of sodium bicarbonate, chamomile and 0.9%
saline are also often used in the Netherlands (Nieweg
 
et al
 
. 1992). The extent to which these mouthwashes
actually help to prevent mucositis is unclear. Clinical
practice guidelines for the prevention and treatment of
cancer therapy-induced oral and gastrointestinal mucosi-
tis have been produced (Rubenstein 
 
et al
 
. 2004), but only
two studies were used as evidence to support the use of
chlorhexidine although there are more studies available in
the international literature. Moreover, there was no meta-
analysis. There is also a review by Clarkson 
 
et al
 
. (2003)
involving patients who received chemotherapy and/or
radiotherapy. However, it is commonly known that
mucositis induced by chemotherapy differs from that
induced by radiation (Rubenstein 
 
et al
 
. 2004). Therefore,
we undertook to search the international literature afresh
to ascertain whether these mouthwashes actually contrib-
ute to the prevention of oral mucositis among patients
who undergo treatment with cytostatic chemotherapy.
 
METHOD
Search strategy
 
The Medline and Cinahl databases were searched for the
relevant literature published from 1992 to the autumn of
2004. The search was restricted to these years in order to
obtain maximal validity in the light of oncology care
today. The search terms ‘mucositis, ‘stomatitis’ and ‘che-
motherapy’ were used in combination with ‘prevention’,
‘mouthwashes’, ‘antiseptic’, ‘oral infection’, ‘chlorhexi-
dine’, ‘chamomile’, ‘PVP-iodine’ and ‘sodium bicarbonate’.
 
Selection criteria
 
All randomized studies of the effect of mouthwashes for
the prevention and amelioration of oral mucositis in
adult patients undergoing chemotherapy were eligible for
this systematic literature study. Two independent asses-
sors C. P. en R. U. selected the articles. The titles and/or
abstracts were used to identify those that meet the inclu-
sion criteria. Studies were selected if they involved using
mouthwashes for oral mucositis, had a controlled study
design, involved adult patients with cancer who received
chemotherapy and included an outcome measure of the
severity of mucositis. If a difference of opinion arose, a
third author was consulted before the article was
included or excluded.
 
Study quality and analysis
 
The quality of a systematic review is related to the quality
of the studies used with randomized controlled trials top-
ping the hierarchy of evidence (Juni 
 
et al
 
. 2001). Quality
assessment allows appraisal of the studies included and
also aids data synthesis. The quality of studies was
assessed for randomization, blinding and the intention-to-
treat analysis. In randomized controlled trials, patients are
randomly assigned to either control or an experimental
group. For blinding, a trial was classified as adequate if it
was described as ‘double-blind’, a type of clinical trial in
which neither the subject nor the investigator knows
what treatment the patient is receiving. An intention-to-
treat analysis specifies how to handle non-compliant
patients in a randomized controlled trial. This analysis
requires that patients be analysed in the groups into which
they  were  randomized,  regardless  of  whether  or  not
they complied with the treatment allocated (Huwiler-
Muntener 
 
et al
 
. 2002).
In a meta-analysis or statistical pooling, the data gath-
ered in the framework of a systematic review are statisti-
cally combined to estimate the effect of the intervention
studied in the research (Thompson 1994).
The  findings  of  the  individual  studies  were  analysed
in  a  meta-analysis  using  the  software  Review  Manager
4.2 (The Cochrane Collaboration 2002). In systematic
reviews, homogeneity refers to the degree to which the
results of studies included in a review are similar. A fixed
effect model was allowed since homogeneity was found
between the studies (Chi-squared test: 
 
P
 
 < 0.1).
This is a statistical model that stipulates that the units
under analysis (people in a trial or study in a meta-analy-
sis) are the ones of interest, and thus constitutes the entire
population of units. Only within-study variation is taken
to influence the uncertainty of results (as reflected in the
confidence interval) of a meta-analysis using a fixed effect
model. Variation between the estimates of effect from
each study (heterogeneity) does not effect the confidence
interval in a fixed effect model.
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RESULTS
 
The search term ‘mucositis or stomatitis’ provided 7589
hits using Medline and Cinahl for the period 1992–2004.
When combined with ‘prevention’, there were still 905
articles. After combining with ‘mouthwashes’, ‘antisep-
tic’, ‘oral infection’, ‘chlorhexidine’, ‘chamomile’, ‘PVP-
iodine’ or ‘sodium bicarbonate’, 20 articles remained
(Fig. 1). Five of these studies investigated chlorhexidine in
a randomized controlled clinical trial (RCT) (Epstein 
 
et al
 
.
1992; Rutkauskas & Davis 1993; Dodd 
 
et al
 
. 1996, 2000;
Pitten 
 
et al
 
. 2003). Three articles were found which inves-
tigated iodine solution as a mouthwash. However, further
investigation revealed that these three articles were all
reports of the same study. Hence only the most complete
one is included in the review (Adamietz 
 
et al
 
. 1998).
One study determined the effects of chamomile solu-
tion (Fidler 
 
et al
 
. 1996). The other 11 articles were
excluded: five were not RCTs but tutor reviews, two
investigated dental problems and two discussed guidelines
for mucositis and were therefore excluded. One study
investigated micronized sucralfate versus salt and soda
mouthwashes in head and neck cancer patients who
received radiation therapy. This study was excluded
because it dealt with radiation-induced mucositis and not
chemotherapy-induced mucositis. Another study also
investigated sodium bicarbonate, but did not use a ran-
domized study design (clinical trial) and was therefore
excluded.
No RCTs investigating sodium bicarbonate were found.
However, three articles were found which investigated
salt and soda, this solution is similar to sodium bicarbon-
ate. In one study, where chlorhexidine was used as the
intervention, the control group used a water, salt and soda
solution. This study was included (Dodd 
 
et al
 
. 2000).
 
Study characteristics
 
The seven studies (Tables 1 and 2) included data from 863
adults with cancer with a mean age of 53.6, 72% of the
patients in the studies received chemotherapy, only 6% of
the patients received HSCT, for 22% of the patients it is
unknown which treatment was received.
The World Health Organization instrument (Miller
 
et al
 
. 1981) was used to score mucositis in three studies
(Fidler 
 
et al
 
. 1996; Adamietz 
 
et al
 
. 1998; Pitten 
 
et al
 
.
2003): one study adapted this scale (Rutkauskas & Davis
1993), two studies (Dodd 
 
et al
 
. 1996, 2000) used the Oral
Assessment Guide (Eilers 
 
et al
 
. 1988) and one study
employed a four-point scale developed by the investigator
(Epstein 
 
et al
 
. 1992). The frequency of assessing mucositis
varied from once to twice a day, once weekly, and on three
separate occasions during treatment.
 
Study quality
 
All studies randomly allocated subjects to either an inter-
vention or a comparison group. Only one study assigned
patients to one of the treatment groups by stratified block
randomization (Pitten 
 
et al
 
. 2003), the blocks being
selected using a set of random sampling numbers. A dou-
ble-blind study design was used in five studies, though the
group assignment was revealed in one study at an early
stage (Rutkauskas & Davis 1993). Another study had an
open study design (Adamietz 
 
et al
 
. 1998) and the last
study did not report blinding at all (Epstein 
 
et al
 
. 1992).
The analysis was conducted on an intention-to-treat basis
in four studies (Epstein 
 
et al
 
. 1992; Fidler 
 
et al
 
. 1996;
Adamietz 
 
et al
 
. 1998; Pitten 
 
et al
 
. 2003).
 
Compliance
 
The compliance of patients with treatment has an
important effect on the results of different studies, and
is therefore an important element to consider (Boudes
1998). However, patient compliance was assessed in only
three studies. Dodd 
 
et al
 
. (2000) collected the mouth
rinse bottles and measured the amounts remaining and
 
Figure 1.
 
Selection of articles.
Mouthwashes or chlorhexidine OR chamomile OR PVP-iodine or sodium bicarbonate = 20
Cancer, neoplasm 
AND 
Chemotherapy  
AND 
 Mucositis OR stomatitis = 7589 
AND
Prevention = 905 
AND
 noisulcxE noisulcnI 
Chlorhexidine    5               
Chamomile  1  
PVP-iodine 1 2 
Tutor reviews  5 
Guidelines  2 
Dental problems  2 
Head and neck cancer  1 
Clinical trial  1 
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compared this with what should have been used. Com-
pliance in this study was very high (92%), although it is
not known if patients disposed of their mouth rinses in
another manner, but the investigators had no reason to
believe that this occurred. However, Epstein 
 
et al
 
. (1992)
found less positive results regarding compliance with
rinsing. In their study, assessment of compliance was
based on medication records and on an interview at
weekly assessment visits. Patients assigned to rinsing
with Nystatin alone or in combination with chlorhexi-
dine showed poor compliance, with only 47% of
patients in the nystatin-chlorhexidine rinse group using
the rinse a 100% of the time, 78% of patients using
chlorhexidine at all times, but 89% of them using the
saline solution group at all times.
Pitten 
 
et al
 
. (2003) used brown glass bottles. On visiting
the patients to assess mucositis, the clinician checked if
the volume remaining in the bottle correlated with the
number of rinses. The findings indicated that the patients
had rinsed properly.
 
Chlorhexidine
 
Chlorhexidine is approved for use as an antibacterial
mouthwash at a concentration of 0.12% and 0.2% to pre-
vent the build-up of dental plaque and to prevent gingivi-
tis (Yates 
 
et al
 
. 2002). Its broad spectrum of antibacterial
activity, minimal systemic absorption and ability to bind
to oral surfaces led to use as prophylaxis in an attempt to
prevent the development of oral mucositis (Matthijs &
Adriaens 2002).
Chlorhexidine has been tested in five randomized stud-
ies for its effects in preventing oral mucositis in patients
undergoing chemotherapy Table 1.
Epstein 
 
et al
 
. (1992) investigated three different
mouthwashes, chlorhexidine, nystatin and a combina-
tion of nystatin-chlorhexidine and compared these with
rinsing using a saline solution. All patients (
 
n
 
 
 
=
 
 86) who
received medical therapy that resulted in severe neutro-
penia were included into the study. Fifty-six patients
(65%) received aggressive chemotherapy for remission
induction or consolidation. Thirty patients (35%)
received HSCT. The patients were asked to rinse with
the mouthwash after eating. Oral hygiene was assessed
using the gingival index and plaque levels, and mucosi-
tis was assessed using a four-point scale specially devel-
oped for the study. Bacterial and fungal oral cultures
were done on a weekly basis. There was no difference in
mucositis between the four groups although bacterial
and fungal infections were found less often among the
patients using chlorhexidine.
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Rutkauskas and Davis (1993) investigated the effect of
chlorhexidine versus a placebo in patients undergoing
HSCT or remission-indication chemotherapy. The study
showed chlorhexidine to be ineffective in preventing
mucositis. Unfortunately, the data were also presented in
a form that made it impossible to include them in the
meta-analysis.
Dodd 
 
et al
 
. (1996) investigated the effect of an instruc-
tion programme for the systematic oral care of 222
patients undergoing chemotherapy provided by nurses in
combination with two mouthwashes (chlorhexidine and
sterile water). The preventative effects of rinsing with
chlorhexidine were no greater than those of rinsing with
sterile water leading the investigators to recommended
rinsing with water only.
Dodd 
 
et al
 
. (2000) also compared the preventative
effects of three mouthwashes (chlorhexidine, salt and soda
in water) and ‘magic mouthwash’ (containing Lidocaine,
Benadryl and Maalox) in patients who received stomato-
toxic chemotherapy at home and were monitored on an
outpatient basis. Nurses used the Oral Assessment Guide
for initial assessment, instructed patients on how to
assess their own mouths, then phoned the patients every
other day to note their oral status. No differences in the
severity of mucositis were found between the three groups
nor were there any significant differences in the time
taken for signs and symptoms of mucositis to subside. The
first signs of mucositis were seen within 6.6 days in the
chlorhexidine group, within 7.0 days in the water/salt/
soda group and within 7.2 days in the ‘magic mouthwash’
group.
Pitten 
 
et al
 
. (2003) investigated chlorhexidine versus
amine-stannous fluoride solution to investigate whether
leucopenic patients who cannot clean their teeth mechan-
ically might have clinical benefit from an antiseptic
mouth rinse containing chlorhexidine. The statistical
analysis showed that there was a significant decrease in
the numbers of microorganisms in the oral cavity during
leucopenia among those in the chlorhexidine group com-
pared with that in the control group. However, this did not
translate into any measurable clinical benefit. Patients
rinsing with chlorhexidine also indicated that the rinsing
was unpleasant and even painful.
 
Power
 
None of the studies reported a power calculation, so we
calculated this from the numbers of patients reported,
assuming an alpha of 0.05 (two-sided) and a clinically
relevant effect size of 20% of the scale range for sever-
ity of mucositis in several studies, or a 20% difference
in frequencies in studies with presence or absence of
mucositis as the main outcome. Only the studies by
Dodd 
 
et al
 
. (1996, 2000) had sufficient power (
 
≥80%).
The study by Fidlet et al. had an estimated power of
70% (Fidler et al. 1996), whereas the power of the other
studies was less.
Meta-analysis
Within the meta-analysis, the results from individual
studies were weighted in inverse proportion to their vari-
ance, resulting in a weight proprtional to the size of the
studies.
Four out of five studies that investigated chlorhexidine
mouthwash for preventing mucositis were eligible for
inclusion in the meta-analysis. Rutkauskas and Davis
(1993) and Pitten et al. (2003) did not state all of the nec-
essary figures for this. The study by Epstein et al. (1992)
had a total of four groups and in the analysis was
approached as two studies, namely chlorhexidine versus
saline solution and chlorhexidine + nystatin versus
nystatin.
The study by Dodd et al. (2000) was also entered as two
studies (chlorhexidine vs. water/salt and soda and chlo-
rhexidine vs. ‘magic mouthwash’).
All the information is contained within the forest plot
graphical representation of the results in Figure 2.
Taken together the results, the five studies showed no
significant effect of chlorhexidine mouthwash (Weighted
mean differences 0.22; 95% confidence interval = −0.20,
0.63). The test for heterogeneity and the test for overall
effect are given at the bottom of the forest plot. It is impor-
tant to remember that heterogeneity may be present when
all or most studies indicate the same treatment effect, but
the size of the effect differs or the trials are contradictory
about the effect (Sutton et al. 1998). The results are con-
sidered homogenous when the effect sizes differ due to
sampling errors.
Other mouthwashes
Table 2 provides an overview of randomized studies into
the  effect  of  mouthwashes  other  than  chlorhexidine
in preventing mucositis in patients undergoing
chemotherapy.
Fidler et al. (1996) evaluated the effect of a chamomile
solution in a group with a total of 164 patients treated
with 5-FU chemotherapy. After randomization, 82
patients received a mouthwash with a chamomile solu-
tion and 82 patients received a mouthwash without. All
patients received oral cryotherapy for 30 min with each
Mouthwashes for oral mucositis
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dose of 5-FU. Mucositis was scored by the physician (scale
of 0–4). The patient also recorded his or her score on a
daily basis. No differences were found between the cham-
omile group and the control group in either the incidence
or severity of mucositis.
Adamietz et al. (1998) investigated the preventative
effects of iodine solution as a mouthwash compared with
rinsing with water in 40 patients given radiochemother-
apy (n = 20 for both groups). The World Health Organiza-
tion criteria for mucositis (scale of 0–4) were used to
estimate the severity and duration of the mucositis. The
iodine group had a significantly less severe mucositis
compared with the control group and the duration of the
mucositis was shorter (2.8 weeks for the iodine group vs.
9.3 weeks for the control group). However, the study was
too small to be confident that the difference observed was
not simply a chance finding.
CONCLUSION
A systematic review was used to assemble and synthesize
the evidence for the effect of commonly used mouth-
washes on the prevention of chemotherapy-induced oral
mucositis. Comprehensive search methods were used to
minimize any bias.
With the exception of iodine solution, none of the stud-
ies investigated were able to demonstrate an effect in pre-
venting mucositis in patients undergoing chemotherapy.
Chlorhexidine
Chlorhexidine is widely used and has been investigated
albeit in various small studies. Individually, the studies
found chlorhexidine to be ineffective and increasing
power through meta-analysis did not alter this. Studies
done before 1992 found a positive effect of rinsing with
chlorhexidine (McGaw & Belch 1985; Ferretti et al. 1988,
1990) whereas those conducted in the period 1992–2004
found either no effect or a negative effect. One possible
explanation could be that bacterial infections were better
controlled and managed after 1992 than before because of
better antibiotics.
The discoloration of teeth, the bitter taste and the
unpleasant sensation experienced together with ineffec-
tiveness are sufficient reasons for recommending sterile
water, 0.9% saline solution or sodium bicarbonate (water,
salt and soda) rather than chlorhexidine. Furthermore,
these alternatives are less expensive and readily available
in everyday nursing practice.
Other mouthwashes
Most of the other formulations had no effect on the
prevention of mucositis. The antifungal drug nystatin,
even in combination with chlorhexidine, was no excep-
tion (Epstein et al. 1992).
Even chamomile, which has an anti-inflammatory
effect, proved ineffective. (Carl & Emrich 1991).
One study did demonstrate that iodine solution was
effective  as  a  mouthwash,  but  this  finding  must  be
treated with caution, due to the small sample sizes
involved. Moreover, side-effects were not reported,
though, when accidentally swallowed, iodine can cause
hyperthyroidism.
The sample sizes varied from 21 to 222 and none of the
studies indicated the power calculation based on a pro-
posed treatment effect even though adequate statistical
power is crucial to minimize type-II or beta errors (Cohen
1992). This shortcoming was compensated to some extent
by the meta-analysis supporting the negative conclusions
for chlorhexidine, which does not apply to other
mouthwashes.
Patient compliance with the intervention has an impor-
tant effect on the results and should always be considered
(Boudes 1998), yet only three studies did so (Epstein et al.
1992; Dodd et al. 2000, Pitten et al. 2003).
Figure 2. Forest plot of mean (SD) mucositis scores. CI, confidence interval; SD, standard deviation; WMD, weighted mean difference.
Review: Chlorhexidine oral rinse
Comparison: 01 Chlorhexidine versus placebo                                                                               
Outcome: 02 mucositis
)dexif( DMWthgieW)dexif( DMWlortnoCtnemtaerTydutS
IC %59%IC %59)DS( naeMn)DS( naeMnyrogetac-bus ro
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Epstein 1992 B          34      3.10(1.74)          16      2.95(1.49)  19.79      0.15 (-0.79, 1.09)       
Dodd 1996              112     14.10(3.08)         110     13.79(2.39)  33.00      0.31 (-0.41, 1.03)       
Dodd 2000 A             51     13.71(2.65)          48     13.21(2.39)  17.56      0.50 (-0.49, 1.49)       
Dodd 2000 B             51     13.71(2.65)          42     13.81(2.38)  16.54     -0.10 (-1.12, 0.92)       
Total (95% CI)    266                         234 100.00      0.22 (-0.20, 0.63)
Test for heterogeneity: X² = 0.80, df = 4 (P = 0.94), I² = 0%
Test for overall effect: Z = 1.03 (P = 0.31)
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Based on our findings and those of others (Clarkson
et al. 2003; Rubenstein et al. 2004), the use of chlorhexi-
dine as well as other mouthwash for preventing oral
mucositis in patients undergoing chemotherapy cannot be
recommended. The use of an iodine solution could be
promising, but should be investigated further.
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